The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bringing experimental therapeutics clinical trials network (ETCTN) to underrepresented population.
 
Joaquina Celebre Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Forty Seven; Hylapharm; Merus NV; Moderna Therapeutics; MorphoSys; Zymeworks
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Astellas Pharma (Inst); Exelixis (Inst); Incyte (Inst); Lilly (Inst); Nektar (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)
 
Gary C. Doolittle
No Relationships to Disclose
 
Rahul Atul Parikh
Stock and Other Ownership Interests - Myovant Sciences (I)
Consulting or Advisory Role - Merck
Research Funding - Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - Patents on DNA repair pathways in cancer. I do not receive any royalties for the same.
 
Anup Kasi
Honoraria - OncLive
Research Funding - Astellas Pharma (Inst); Bavarian Nordic (Inst); Cardiff Oncology (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Halozyme (Inst); Novocure (Inst); Rafael Pharmaceuticals (Inst); TESARO (Inst)
Travel, Accommodations, Expenses - Halozyme; Rafael Pharmaceuticals
 
Elizabeth Marie Wulff-Burchfield
Stock and Other Ownership Interests - Immunomedics (I); Nektar (I)
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AVEO; Bristol-Myers Squibb; Exelixis; Janssen Oncology
Research Funding - Pfizer
 
Benjamin Powers
No Relationships to Disclose
 
Robert E. Pluenneke
No Relationships to Disclose
 
Marc Steven Hoffmann
Consulting or Advisory Role - AstraZeneca/Merck; AstraZeneca/Merck; BeiGene; Janssen; Kite, a Gilead Company; Novartis; Pharmacyclics; TG Therapeutics
 
Abdulraheem Yacoub
Stock and Other Ownership Interests - Ardelyx; Cara Therapeutics; Dynavax Technologies; Hylapharm
Consulting or Advisory Role - Incyte
Speakers' Bureau - Agios; Incyte; Novartis; Seagen
 
Anwaar Saeed
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Exelixis; Five Prime Therapeutics; Pfizer
Speakers' Bureau - Daiichi Sankyo/Astra Zeneca
Research Funding - Actuate Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/UCB Japan (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); KAHR Medical (Inst); Merck Sharp & Dohme (Inst); Seagen (Inst)
 
Larry R. Corum
No Relationships to Disclose
 
Tara L. Lin
Research Funding - Aptevo Therapeutics (Inst); Astellas Pharma (Inst); Bio-Path Holdings, Inc (Inst); Celgene (Inst); Celyad (Inst); CicloMed (Inst); Cleave Biosciences (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); incyte (Inst); Novartis (Inst); Pfizer (Inst); Prescient Therapeutics (Inst); Seagen (Inst); Tolero Pharmaceuticals (Inst); Trovagene (Inst)
 
Weijing Sun
Research Funding - Merck (Inst)
 
Margaret M. Mooney
No Relationships to Disclose
 
Jeffrey Moscow
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Brittany Waters
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
Steven Gore
No Relationships to Disclose
 
Roy A. Jensen
No Relationships to Disclose